Nuvalent Inc (NUVL)
86.88
-3.30
(-3.66%)
USD |
NASDAQ |
Nov 15, 16:00
86.84
-0.04
(-0.05%)
After-Hours: 20:00
Nuvalent Total Liabilities (Quarterly): 67.73M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 67.73M |
| June 30, 2024 | 38.19M |
| March 31, 2024 | 33.43M |
| December 31, 2023 | 31.82M |
| September 30, 2023 | 29.10M |
| June 30, 2023 | 20.80M |
| March 31, 2023 | 17.02M |
| December 31, 2022 | 19.48M |
| Date | Value |
|---|---|
| September 30, 2022 | 12.98M |
| June 30, 2022 | 10.04M |
| March 31, 2022 | 8.124M |
| December 31, 2021 | 8.787M |
| September 30, 2021 | 6.842M |
| June 30, 2021 | 191.24M |
| March 31, 2021 | 3.11M |
| December 31, 2020 | 41.97M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.11M
Minimum
Mar 2021
191.24M
Maximum
Jun 2021
33.79M
Average
20.14M
Median
Total Liabilities (Quarterly) Benchmarks
| Viking Therapeutics Inc | 26.44M |
| Bristol-Myers Squibb Co | 76.47B |
| Replimune Group Inc | 116.74M |
| Moderna Inc | 3.876B |
| NovaBay Pharmaceuticals Inc | 2.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.189B |
| Shareholders Equity (Quarterly) | 1.121B |